Veracyte receives Medicare coverage for bladder cancer monitoring test
Go back to Veracyte receives Medicare coverage for bladder cancer monitoring test| VERACYTE (NASDAQ: VCYT) | Delayed: 53.18 -0.01 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.19 | 52 Week High | $8.45 | |||
| Open | $52.79 | 52 Week Low | $4.21 | |||
| Day High | $54.12 | P/E | N/A | |||
| Day Low | $52.65 | EPS | $-1.52 | |||
| Volume | 307,105 | |||||
